Biopharmaceutical Tubing Global Market Report 2026
상품코드:1939352
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오의약품용 튜브 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 47억 9,000만 달러에서 2026년에는 53억 2,000만 달러로, CAGR 11.2%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 바이오의약품 생산 능력의 확대, 멸균 처리 부품의 표준화, 의약품 생산 라인에서 실리콘 및 PVC 튜브의 조기 도입, 위탁 생산 및 충전 및 마무리 공정 증가, 재료의 생체 적합성 및 순도에 대한 규제 당국의 중요성 증가 등이 주요 요인으로 꼽힙니다. 있습니다.
바이오의약품용 튜브 시장 규모는 향후 수년간 급성장이 전망되고 있습니다. 2030년에는 81억 2,000만 달러에 달하며, CAGR은 11.1%로 예측되고 있습니다. 예측 기간 중 성장 요인으로는 바이오의약품 및 세포 및 유전자 치료 제품 파이프라인 확대, 일회용 및 일회용 처리 시스템으로의 전환 가속화, 고성능 TPE 및 폴리올레핀 튜브에 대한 수요 증가, 자동화 생산 및 폐쇄형 워크플로우 확대, 첨단 바이오프로세싱 기술 및 무균 이송 기술에 대한 투자 증가 등이 있습니다. 및 무균 이송 기술에 대한 투자 증가를 들 수 있습니다. 예측 기간 중 주요 동향으로는 바이오의약품 제조에서 고순도 및 생체 적합성 튜브의 사용 증가, 일회용 및 무균 이송 튜브 시스템의 채택 확대, 의약품 제조 및 충전 공정에서 정밀 유체 취급에 대한 수요 증가, 제약, 의료기기 및 R&D 분야에서의 튜브 사용 확대, 재료 내구성 및 무균성 보장, 오염에 대한 집중적인 관심 등이 있습니다. 재료 내구성, 무균성 보장 및 오염 관리에 대한 관심 증가 등을 꼽을 수 있습니다.
향후 수년간 맞춤형 의료 증가가 바이오의약품용 튜브 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤형 의료는 환자 개개인의 고유한 특성에 따라 의료적 결정, 관행, 개입, 치료를 맞춤화하는 의료 접근법입니다. 맞춤형 의료에 대한 관심이 높아지는 배경에는 주로 유전자 조사의 발전이 있습니다. 이를 통해 개인의 유전자 구성, 생활습관, 특정 건강 상태에 따라 치료 전략을 조정할 수 있게 되었습니다. 바이오의약품용 튜브는 개인 맞춤형 치료와 환자 개개인의 요구에 맞는 치료법 투여에 필수적인 정확하고 무균적이며 신뢰할 수 있는 유체 이송을 실현함으로써 맞춤형 의료를 지원하는 중요한 역할을 하고 있습니다. 예를 들어 미국 비영리단체 '맞춤형 의료연합'에 따르면 2024년 2월 현재 미국 식품의약국(FDA)은 2023년 26개의 새로운 개인맞춤형 치료법을 승인했습니다. 이는 2022년 18건에서 증가한 것으로, 맞춤형 의료 승인 건수에서 역대 최고 수준의 연간 증가율을 보이고 있습니다. 따라서 맞춤형 의료 증가는 바이오의약품용 튜브 시장의 성장에 기여하고 있습니다.
바이오의약품용 튜브 시장의 주요 기업은 첨단 바이오의약품 응용 분야에서 성능, 무균성, 유체 처리 능력을 향상시키기 위해 생체흡수성 튜브와 같은 차세대 솔루션으로 제품 라인업을 확장하고 있습니다. 생체흡수성 튜브는 사용 후 제거할 필요가 없고, 체내에서 서서히 분해 및 흡수되는 소재로 만들어졌습니다. 예를 들어 2023년 9월, 미국에 본사를 둔 첨단 폴리머 솔루션 프로바이더인 제우스 컴퍼니(Zeus Company Inc.)는 생체흡수성 혈관스캐폴드(BRS)용으로 설계된 차세대 생체흡수성 제품인 'Absorv XSE-oriented tubing'을 발표했습니다. 발표했습니다. 이 혁신을 통해 의료기기 제조업체는 관상동맥 질환 치료 이외의 BRS 응용 분야를 모색할 수 있으며, 다양한 시술에서 금속 스텐트를 대체할 수 있습니다. 새로운 튜브는 벽 두께와 크기 균일성이 향상되어 레이저 절단 공정의 효율성과 사용 가능한 스텐트 증가를 실현합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Biopharmaceutical tubing refers to specialized tubing used in the production and handling of biopharmaceutical products. It is engineered to meet rigorous standards for sterility, biocompatibility, and precision to ensure the safe and effective handling of sensitive materials throughout both manufacturing and administration processes.
The main products in the biopharmaceutical tubing market include silicone tubing, polyvinyl chloride (PVC) tubing, polyolefin tubing, and thermoplastic elastomer tubing. Silicone biopharmaceutical tubing is known for its flexibility and high purity, made from silicone rubber and specifically designed for use in the biopharmaceutical industry. Manufacturing processes for these tubes include extrusion and vulcanization, with applications spanning pharmaceuticals, medical devices, research and development, and other areas.
Tariffs are influencing the biopharmaceutical tubing market by increasing the cost of specialty polymers, silicone compounds, extrusion-grade resins, and sterile packaging materials sourced through global supply networks, resulting in higher production and procurement expenses for manufacturers and end users. The impact is particularly evident across silicone, pvc, and thermoplastic elastomer tubing categories produced in Asia-Pacific and European industrial hubs that rely on imported raw materials and precision extrusion equipment. Pharmaceutical manufacturers, medical device producers, and research facilities are experiencing pricing pressures and extended sourcing cycles as tariff-related costs are passed along the supply chain. However, tariffs are also encouraging localized resin compounding, regional extrusion capabilities, and domestic component assembly, which may strengthen supply resilience and support long-term manufacturing competitiveness.
The biopharmaceutical tubing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical tubing market statistics, including biopharmaceutical tubing industry global market size, regional shares, competitors with a biopharmaceutical tubing market share, detailed biopharmaceutical tubing market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical tubing industry. This biopharmaceutical tubing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biopharmaceutical tubing market size has grown rapidly in recent years. It will grow from $4.79 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increasing standardization of sterile processing components, early adoption of silicone and pvc tubing in drug production lines, growth in contract manufacturing and fill-finish activities, rising regulatory emphasis on material biocompatibility and purity.
The biopharmaceutical tubing market size is expected to see rapid growth in the next few years. It will grow to $8.12 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growing pipeline of biologics and cell and gene therapy products, increasing shift toward single-use and disposable processing systems, higher demand for high-performance tpe and polyolefin tubing, expansion of automated production and closed system workflows, rising investment in advanced bioprocessing and aseptic transfer technologies. Major trends in the forecast period include increasing use of high-purity and biocompatible tubing in biopharmaceutical processing, rising adoption of single-use and sterile transfer tubing systems, growing demand for precision fluid handling in drug manufacturing and fill-finish operations, expansion of tubing applications across pharmaceutical, medical device, and r&d settings, focus on material durability, sterility assurance, and contamination control.
The growing number of personalized medicines is expected to drive the expansion of the biopharmaceutical tubing market in the coming years. Personalized medicine is a healthcare approach that customizes medical decisions, practices, interventions, and treatments based on the unique characteristics of each patient. The increasing focus on personalized medicine is largely driven by advances in genetic research, which allow treatment strategies to be tailored according to an individual's genetic makeup, lifestyle, and specific health conditions. Biopharmaceutical tubing plays a critical role in supporting personalized medicine by enabling accurate, sterile, and dependable fluid transfer, which is essential for administering customized therapies and treatments designed for individual patient needs. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the US Food and Drug Administration approved 26 new personalized therapies in 2023, compared to 18 approvals in 2022, representing one of the highest yearly increases in personalized medicine approvals. Therefore, the rising number of personalized medicines is contributing to the growth of the biopharmaceutical tubing market.
Key players in the biopharmaceutical tubing market are advancing their product offerings with next-generation solutions, such as bioabsorbable tubing, to enhance performance, sterility, and fluid handling for advanced biopharmaceutical applications. Bioabsorbable tubing is made from materials that gradually break down and are absorbed by the body, eliminating the need for removal after use. For example, in September 2023, Zeus Company Inc., a US-based provider of advanced polymer solutions, introduced the Absorv XSE-oriented tubing, a next-generation bioabsorbable product designed for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to explore BRS applications beyond treating coronary artery disease and potentially replace metallic stents in various procedures. The new tubing offers improved wall thickness and sizing uniformity, enhancing efficiency during laser cutting processes and resulting in more usable scaffolds.
In February 2024, EQT Private Equity, a Sweden-based investment management firm, acquired Zeus Company Inc. for $3.4 billion. This acquisition aims to support Zeus's growth by investing in additional production capacity, research and development, and operational excellence, particularly in medical tubing technology. Zeus Company Inc. is a US-based manufacturer known for precision polymer extrusions and custom tubing.
Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Optinova AB, ESI Ultrapure
North America was the largest region in the biopharmaceutical tubing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biopharmaceutical tubing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biopharmaceutical tubing market consists of sales of polytetrafluoroethylene (PTFE) tubing, ethylene-vinyl acetate (EVA) tubing, and rubber tubing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biopharmaceutical Tubing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biopharmaceutical tubing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biopharmaceutical tubing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical tubing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Use Of High-Purity And Biocompatible Tubing In Biopharmaceutical Processing
4.2.2 Rising Adoption Of Single-Use And Sterile Transfer Tubing Systems
4.2.3 Growing Demand For Precision Fluid Handling In Drug Manufacturing And Fill-Finish Operations
4.2.4 Expansion Of Tubing Applications Across Pharmaceutical, Medical Device, And R&D Settings
4.2.5 Focus On Material Durability, Sterility Assurance, And Contamination Control
5. Biopharmaceutical Tubing Market Analysis Of End Use Industries
5.1 Pharmaceutical Manufacturers
5.2 Biopharmaceutical Production Facilities
5.3 Medical Device Companies
5.4 Contract Manufacturing Organizations
5.5 Research And Development Laboratories
6. Biopharmaceutical Tubing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Biopharmaceutical Tubing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Biopharmaceutical Tubing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Biopharmaceutical Tubing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Biopharmaceutical Tubing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Biopharmaceutical Tubing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Biopharmaceutical Tubing Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Biopharmaceutical Tubing Market Segmentation
9.1. Global Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.2. Global Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Extrusion, Vulcanization, Other Manufacturing Processes
9.3. Global Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical, Medical Devices, Research And Development, Other Applications
9.4. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Silicone Tubing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Polyolefin Tubing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Biopharmaceutical Tubing Market, Sub-Segmentation Of Thermoplastic Elastomer Tubing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Biopharmaceutical Tubing Market
12.1. China Biopharmaceutical Tubing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Biopharmaceutical Tubing Market
13.1. India Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Biopharmaceutical Tubing Market
14.1. Japan Biopharmaceutical Tubing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Biopharmaceutical Tubing Market
15.1. Australia Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Biopharmaceutical Tubing Market
16.1. Indonesia Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Biopharmaceutical Tubing Market
17.1. South Korea Biopharmaceutical Tubing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Biopharmaceutical Tubing Market
19.1. South East Asia Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Biopharmaceutical Tubing Market
20.1. Western Europe Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Biopharmaceutical Tubing Market
21.1. UK Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Biopharmaceutical Tubing Market
22.1. Germany Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Biopharmaceutical Tubing Market
23.1. France Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Biopharmaceutical Tubing Market
24.1. Italy Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Biopharmaceutical Tubing Market
25.1. Spain Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Biopharmaceutical Tubing Market
26.1. Eastern Europe Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Biopharmaceutical Tubing Market
27.1. Russia Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Biopharmaceutical Tubing Market
28.1. North America Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Biopharmaceutical Tubing Market
29.1. USA Biopharmaceutical Tubing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Biopharmaceutical Tubing Market
31.1. South America Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Biopharmaceutical Tubing Market
32.1. Brazil Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Biopharmaceutical Tubing Market
33.1. Middle East Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Biopharmaceutical Tubing Market
34.1. Africa Biopharmaceutical Tubing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Biopharmaceutical Tubing Market, Segmentation By Product, Segmentation By Manufacturing Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Biopharmaceutical Tubing Market Regulatory and Investment Landscape
36. Biopharmaceutical Tubing Market Competitive Landscape And Company Profiles
36.1. Biopharmaceutical Tubing Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Biopharmaceutical Tubing Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Biopharmaceutical Tubing Market Company Profiles
36.3.1. Compagnie de Saint-Gobain S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Parker Hannifin Corporation Overview, Products and Services, Strategy and Financial Analysis
37. Biopharmaceutical Tubing Market Other Major And Innovative Companies
DuPont de Nemours Inc., Freudenberg Group, Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Optinova AB
38. Global Biopharmaceutical Tubing Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Biopharmaceutical Tubing Market
40. Biopharmaceutical Tubing Market High Potential Countries, Segments and Strategies
40.1 Biopharmaceutical Tubing Market In 2030 - Countries Offering Most New Opportunities
40.2 Biopharmaceutical Tubing Market In 2030 - Segments Offering Most New Opportunities
40.3 Biopharmaceutical Tubing Market In 2030 - Growth Strategies
